CAT
40
-2
CMS
58
-3
BIIB
39
-3
TSCO
46
-3
AN
35
6
EL
24
-4
K
59
2
PEG
46
2
WHR
42
2
ES
38
2
WU
48
-4
KMI
59
4
PYPL
24
2
COP
47
17
VIX
80
-6
FMC
31
-5
CAH
51
4
NFLX
62
4
TRIP
40
3
IFF
41
-3
CAT
40
-2
CMS
58
-3
BIIB
39
-3
TSCO
46
-3
AN
35
6
EL
24
-4
K
59
2
PEG
46
2
WHR
42
2
ES
38
2
WU
48
-4
KMI
59
4
PYPL
24
2
COP
47
17
VIX
80
-6
FMC
31
-5
CAH
51
4
NFLX
62
4
TRIP
40
3
IFF
41
-3
Financhill
Back

Greenlight Capital Re Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
45

GLRE
Greenlight Capital Re

Last Price:
$13.20
Seasonality Move:
-0.41%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.36
Seasonality Move:
6.73%
Sell
45
Greenlight Capital Re (GLRE) is a Sell

Is Greenlight Capital Re a Buy, Sell or Hold?

  • The current Greenlight Capital Re [GLRE] share price is $12.85. The Score for GLRE is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • GLRE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GLRE Stock Price Chart

What is Greenlight Capital Re's stock price today?

  • The Greenlight Capital Re share price today is $12.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLRE is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

GLRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 34.9 Sell
Chaikin Money Flow: -150154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.25 - 13.81) Sell
Bollinger Bands (100): (13.41 - 14.59) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

GLRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.67 Sell
20-day SMA: 13.52 Sell
50-day SMA: 13.68 Sell
200-day SMA: 13.64 Sell
8-day EMA: 13.5 Sell
20-day EMA: 13.58 Sell
50-day EMA: 13.72 Sell
200-day EMA: 13.47 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Greenlight Capital Re Earnings Growth & GLRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Greenlight Capital Re Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):